The two oral obesity drugs are in clinical and preclinical phases, respectively
The question that matters clinically is whether a given patient is a good candidate, what the right protocol looks like for their specific goals and lab results, and whether they have access to a supervised framework that can catch the small number of patients for whom these compounds are not appropriate before they start rather than after
At Cymbiotika, we believe that transparency and education are the keys to a successful health journey
The same applies to vitiligo
Employers should cover all evidence-based obesity care options, including drugs, nutrition therapy, behavioral health services and surgery, the groups say
Currently, a number of drugs have been launched worldwide, which not only benefit type 2 diabetes patients, but also bring hope to many obesity patients